| Ringversuch | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
| ALK-IHC | X | |||||
| ALK-ISH | ||||||
| BRAF | X | X | X | X | ||
| BRCA1 | X | |||||
| CD117 | X | X | ||||
| Chromogranin | X | |||||
| DNA-Mismatch-Repair | X | |||||
| ER Mamma | X | X | ||||
| EGFR | X | X | X | |||
| ERez_161 | X | |||||
| FGFR3 | X | |||||
| GIST Zertifikat | X | X | ||||
| GIST Urkunde | X | |||||
| HER2 Magen_IHC | X | |||||
| HER2 Magen_ISH | X | |||||
| HER2_Mamma | X | |||||
| HER2 Mamma_ISH | X | X | X | |||
| HPV | X | |||||
| PR-Mamma | X | X | ||||
| Keratine | X | |||||
| Ki-67 | X | X | ||||
| KlonML-B-Zellen | X | X | ||||
| KlonML-T-Zellen | X | |||||
| MLH1 | X | |||||
| MMRD | X | X | ||||
| MSI | X | X | X | |||
| NEM (Immunhisto) | X | |||||
| Östrogen-Rez | X | |||||
| Panel ER | X | |||||
| PIK3CA Gewebe | X | |||||
| PIK3CA Liquid | X | |||||
| PD-L1 | X | X | X | |||
| PRez_161 | X | |||||
| Progesteron-Rez | X | |||||
| RAS | X | X | ||||
| RAS-Mutationsanalyse | X | |||||
| RET Mutations-analyse(MolPath) | X | |||||
| RET Fusionen (NGS) | X | |||||
| RET Fusionen (ISH) | X | |||||
| T790M | X | X | ||||
| TBC-PCR | X | |||||
| UK Panel ER | X | |||||
| UK PIK3CA Gewebe | X | |||||
| UK PIK3CA Liquid | X | |||||
| UK PD-L1 HNSCC | X |
„X“ bezeichnet die Teilnahme am Ringversuch in dem Jahr.
Kein „X“ bedeutet also NICHT, dass der Teilnehmer in dem Jahr nicht bestanden hat.
